Finance

Lists
CSBR:NASDAQ
Champions Oncology Inc
4,88 $
0,00%
(0,00) 1D
1 қаз., 15:58:29 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CSBR...
Mkt. cap
67,92 млн
Avg. vol.
11,99 мың
Volume
278,00
52-wk high
8,31 $
52-wk low
4,64 $
EPS
-0,08 $
Beta
0,43
Shares outstanding
13,92 млн
No. of employees
217
Mkt. cap
67,92 млн
Avg. vol.
11,99 мың
Volume
278,00
52-wk high
8,31 $
52-wk low
4,64 $
EPS
-0,08 $
Beta
0,43
Shares outstanding
13,92 млн
No. of employees
217
News stories
From web sources and news partners
About Champions Oncology Inc
CEO-
Employees217
Founded1985
HeadquartersХаккенсак, Нью-Джерси, Америка Құрама Штаттары
Sector-
Websitechampionsoncology.com
Analyst
Recommendation
Action
Price target
Projected
Date
Matt Hewitt
Craig-Hallum
Buy
Maintained
12,00 $
+145,9%
12/16/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қаз.
2026 ж. қаң.
2026 ж. сәу.
2026 ж. шіл.
Revenue
15,04 млн
16,56 млн
13,84 млн
15,23 млн
Cost of goods sold
7,26 млн
8,83 млн
6,81 млн
7,53 млн
Cost of revenue
7,26 млн
8,83 млн
6,81 млн
7,53 млн
Research and development expenses
2,62 млн
2,27 млн
2,12 млн
2,34 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,97 млн
5,64 млн
5,43 млн
5,76 млн
Operating expense
7,59 млн
7,91 млн
7,55 млн
8,11 млн
Total operating expenses
14,85 млн
16,75 млн
14,36 млн
15,64 млн
Operating income
185,00 м.
-187,00 м.
-521,00 м.
-409,00 м.
Other non operating income
70,00 мың
39,00 мың
27,00 мың
-6,00 мың
EBT including unusual items
255,00 м.
-237,00 м.
-495,00 м.
-415,00 м.
EBT excluding unusual items
255,00 м.
-148,00 м.
-494,00 м.
-415,00 м.
Income tax expense
18,00 мың
42,00 мың
172,00 м.
11,00 мың
Effective tax rate
7,06%
-17,72%
-34,75%
-2,65%
Other operating expenses
-
-
-
-
Net income
268,00 м.
-279,00 м.
-667,00 м.
-426,00 м.
Net profit margin
1,78%
-1,68%
-4,82%
-2,80%
Earnings per share
0,06
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
542,00 м.
154,00 м.
-200,00 м.
-95,00 мың
Gain or loss from assets sale
-
90,00 мың
1,00 мың
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары